{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:33:23Z","timestamp":1781530403438,"version":"3.54.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Forensic Toxicol"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Designer benzodiazepines (DBZDs) increasingly emerged on the novel psychoactive substance (NPS) market in the last few years. They are usually sold as readily available alternatives to prescription benzodiazepines (BZDs) or added to counterfeit medicines. BZDs are generally considered relatively safe drugs due to the low risk of serious acute adverse effects in mono-intoxication, though e.g., alprazolam seems to display an elevated risk of respiratory depression. Here we report on a fatal intoxication involving the novel DBZD flualprazolam.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A complete postmortem examination was performed. General unknown screenings and analysis of drugs of abuse were performed on postmortem samples by immunoassay, gas chromatography\u2013mass spectrometry and liquid chromatography\u2013mass spectrometry. The standard addition method was employed to quantify flualprazolam in postmortem blood and tissues. Finally, a toxicological significance score (TSS) was assigned.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Flualprazolam was detected in heart serum (25.4\u00a0ng\/mL) and peripheral blood (21.9\u00a0ng\/mL) as well as in urine, stomach contents, brain, liver and kidney (65.2\u2013323\u00a0ng\/g). The cause of death was deemed as central nervous system (CNS) and respiratory depression with agonal aspiration of stomach contents, in the setting of a multiple drug intake. Given the concentration levels of the co-consumed CNS depressants, the contribution of flualprazolam to the death was considered likely (TSS of 3).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results support that highly potent DBZDs like flualprazolam carry an elevated risk for unintended toxicity, especially in association with other CNS depressants. A multidisciplinary evaluation of fatalities remains mandatory, especially when pharmacological\/toxicological data on intoxicating compounds are lacking. To our knowledge this is the first report of flualprazolam concentrations in solid tissues in human.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11419-021-00591-w","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T09:03:25Z","timestamp":1628672605000},"page":"180-188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A case of fatal multidrug intoxication involving flualprazolam: distribution in body fluids and solid tissues"],"prefix":"10.1007","volume":"40","author":[{"given":"Arianna","family":"Giorgetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela J.","family":"Sommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus Gro\u00dfe","family":"Perdekamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1883-2804","authenticated-orcid":false,"given":"Volker","family":"Auw\u00e4rter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,11]]},"reference":[{"key":"591_CR1","unstructured":"EMCDDA (2020). European drug report 2020: trends and developments. https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/13236\/TDAT20001ENN_web.pdf. Accessed 7 Jul 2021"},{"key":"591_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1007\/s11419-015-0277-6","volume":"33","author":"LM Huppertz","year":"2015","unstructured":"Huppertz LM, Bisel P, Westphal F, Franz F, Auw\u00e4rter V, Moosmann B (2015) Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites. Forensic Toxicol 33:388\u2013395. https:\/\/doi.org\/10.1007\/s11419-015-0277-6","journal-title":"Forensic Toxicol"},{"key":"591_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s11419-013-0187-4","volume":"31","author":"B Moosmann","year":"2013","unstructured":"Moosmann B, Hutter M, Huppertz LM, Ferlaino S, Redlingsh\u00f6fer L, Auw\u00e4rter V (2013) Characterization of the designer benzodiazepine pyrazolam and its detectability in human serum and urine. Forensic Toxicol 31:263\u2013271. https:\/\/doi.org\/10.1007\/s11419-013-0187-4","journal-title":"Forensic Toxicol"},{"key":"591_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/15563650.2018.1506130","volume":"57","author":"M B\u00e4ckberg","year":"2019","unstructured":"B\u00e4ckberg M, Pettersson Bergstrand M, Beck O, Helander A (2019) Occurrence and time course of NPS benzodiazepines in Sweden - results from intoxication cases in the STRIDA project. Clin Toxicol 57:203\u2013212. https:\/\/doi.org\/10.1080\/15563650.2018.1506130","journal-title":"Clin Toxicol"},{"key":"591_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2796.1989.tb01365.x","volume":"226","author":"J H\u00f6jer","year":"1989","unstructured":"H\u00f6jer J, Baehrendtz S, Gustafsson L (1989) Benzodiazepine poisoning: experience of 702 admissions to an intensive care unit during a 14-year period. J Intern Med 226:117\u2013122. https:\/\/doi.org\/10.1111\/j.1365-2796.1989.tb01365.x","journal-title":"J Intern Med"},{"key":"591_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/s0379-0738(99)00118-8","volume":"105","author":"K Michaud","year":"1999","unstructured":"Michaud K, Augsburger M, Romain N, Giroud C, Mangin P (1999) Fatal overdose of tramadol and alprazolam. Forensic Sci Int 105:185\u2013189. https:\/\/doi.org\/10.1016\/s0379-0738(99)00118-8","journal-title":"Forensic Sci Int"},{"key":"591_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","volume":"125","author":"JD Jones","year":"2012","unstructured":"Jones JD, Mogali S, Comer SD (2012) Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend 125:8\u201318. https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.07.004","journal-title":"Drug Alcohol Depend"},{"key":"591_CR8","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1001\/jamainternmed.2016.4306","volume":"176","author":"AM Arens","year":"2016","unstructured":"Arens AM, van Wijk XM, Vo KT, Lynch KL, Wu AH, Smollin CG (2016) Adverse effects from counterfeit alprazolam tablets. JAMA Intern Med 176:1554\u20131555. https:\/\/doi.org\/10.1001\/jamainternmed.2016.4306","journal-title":"JAMA Intern Med"},{"key":"591_CR9","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/wps.20236","volume":"14","author":"B Moosmann","year":"2015","unstructured":"Moosmann B, King LA, Auw\u00e4rter V (2015) Designer benzodiazepines: a new challenge. World Psychiatry 14:248. https:\/\/doi.org\/10.1002\/wps.20236 (open access article)","journal-title":"World Psychiatry"},{"key":"591_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/978-3-030-10561-7","volume-title":"New psychoactive substances. Handbook of experimental pharmacology","author":"B Moosmann","year":"2018","unstructured":"Moosmann B, Auw\u00e4rter V (2018) Designer benzodiazepines: another class of new psychoactive substances. In: Maurer HH, Brandt S (eds) New psychoactive substances. Handbook of experimental pharmacology, 1st edn. Springer, Cham, pp 383\u2013410. https:\/\/doi.org\/10.1007\/978-3-030-10561-7","edition":"1"},{"key":"591_CR11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1093\/jat\/bkaa070","volume":"45","author":"D Papsun","year":"2021","unstructured":"Papsun D, Krotulski AJ, Homan J, Temporal KDH, Logan BK (2021) Flualprazolam blood concentrations in 197 forensic investigation cases. J Anal Toxicol 45:226\u2013232. https:\/\/doi.org\/10.1093\/jat\/bkaa070","journal-title":"J Anal Toxicol"},{"key":"591_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2019.110101","volume":"307","author":"P Kriikku","year":"2020","unstructured":"Kriikku P, Rasanen I, Ojanper\u00e4 I, Thelander G, Kronstrand R, Vikingsson S (2020) Femoral blood concentrations of flualprazolam in 33 postmortem cases. Forensic Sci Int 307:110101. https:\/\/doi.org\/10.1016\/j.forsciint.2019.110101","journal-title":"Forensic Sci Int"},{"key":"591_CR13","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/jat\/bkaa043","volume":"44","author":"G Heide","year":"2020","unstructured":"Heide G, H\u00f8iseth G, Middelkoop G, \u00d8iestad \u00c5ML (2020) Blood concentrations of designer benzodiazepines: relation to impairment and findings in forensic cases. J Anal Toxicol 44:905\u2013914. https:\/\/doi.org\/10.1093\/jat\/bkaa043","journal-title":"J Anal Toxicol"},{"key":"591_CR14","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-2953","volume":"146","author":"A Blumenberg","year":"2020","unstructured":"Blumenberg A, Hughes A, Reckers A, Ellison R, Gerona R (2020) Flualprazolam: report of an outbreak of a new psychoactive substance in adolescents. Pediatrics 146:e20192953. https:\/\/doi.org\/10.1542\/peds.2019-2953 (open access article)","journal-title":"Pediatrics"},{"key":"591_CR15","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s11419-020-00565-4","volume":"39","author":"P-SA Ntoupa","year":"2021","unstructured":"Ntoupa P-SA, Papoutsis II, Dona AA, Spiliopoulou CA, Athanaselis SA (2021) A fluorine turns a medicinal benzodiazepine into NPS: the case of flualprazolam. Forensic Toxicol 39:368\u2013376. https:\/\/doi.org\/10.1007\/s11419-020-00565-4 (open access article)","journal-title":"Forensic Toxicol"},{"key":"591_CR16","unstructured":"World Health Organization (WHO) (2019) Critical review report: flualprazolam. https:\/\/www.who.int\/medicines\/access\/controlled-substances\/Final_Flualprazolam.pdf?ua=1.\u00a0Accessed 7 Jul 2021"},{"key":"591_CR17","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/jat\/bkaa019","volume":"44","author":"L Wagmann","year":"2020","unstructured":"Wagmann L, Manier SK, Bambauer TP, Felske C, Eckstein N, Flockerzi V, Meyer MR (2020) Toxicokinetics and analytical toxicology of flualprazolam: metabolic fate, isozyme mapping, human plasma concentration and main urinary excretion products. J Anal Toxicol 44:549\u2013558. https:\/\/doi.org\/10.1093\/jat\/bkaa019","journal-title":"J Anal Toxicol"},{"key":"591_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.scijus.2017.12.004","volume":"58","author":"L Waters","year":"2018","unstructured":"Waters L, Manchester KR, Maskell PD, Haegeman C, Haider S (2018) The use of a quantitative structure-activity relationship (QSAR) model to predict GABA-A receptor binding of newly emerging benzodiazepines. Sci Justice 58:219\u2013225. https:\/\/doi.org\/10.1016\/j.scijus.2017.12.004","journal-title":"Sci Justice"},{"key":"591_CR19","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/dta.1628","volume":"6","author":"B Moosmann","year":"2014","unstructured":"Moosmann B, Bisel P, Auw\u00e4rter V (2014) Characterization of the designer benzodiazepine diclazepam and preliminary data on its metabolism and pharmacokinetics. Drug Test Anal 6:757\u2013763. https:\/\/doi.org\/10.1002\/dta.1628","journal-title":"Drug Test Anal"},{"key":"591_CR20","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/dta.2391","volume":"10","author":"K Koch","year":"2018","unstructured":"Koch K, Auw\u00e4rter V, Hermanns-Clausen M, Wilde M, Neukamm MA (2018) Mixed intoxication by the synthetic opioid U-47700 and the benzodiazepine flubromazepam with lethal outcome: pharmacokinetic data. Drug Test Anal 10:1336\u20131341. https:\/\/doi.org\/10.1002\/dta.2391","journal-title":"Drug Test Anal"},{"key":"591_CR21","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/dta.2225","volume":"10","author":"S Elliott","year":"2018","unstructured":"Elliott S, Sedefov R, Evans-Brown M (2018) Assessing the toxicological significance of new psychoactive substances in fatalities. Drug Test Anal 10:120\u2013126. https:\/\/doi.org\/10.1002\/dta.2225","journal-title":"Drug Test Anal"},{"key":"591_CR22","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/dta.2203","volume":"10","author":"LM Huppertz","year":"2018","unstructured":"Huppertz LM, Moosmann B, Auw\u00e4rter V (2018) Flubromazolam \u2013 basic pharmacokinetic evaluation of a highly potent designer benzodiazepine. Drug Test Anal 10:206\u2013211. https:\/\/doi.org\/10.1002\/dta.2203","journal-title":"Drug Test Anal"},{"key":"591_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/1455072517706304","volume":"34","author":"M Andersson","year":"2017","unstructured":"Andersson M, Kjellgren A (2017) The slippery slope of flubromazolam: experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum. Nordisk Alkohl Nark 34:217\u2013229. https:\/\/doi.org\/10.1177\/1455072517706304 (open access article)","journal-title":"Nordisk Alkohl Nark"},{"key":"591_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.9740\/mhc.2019.05.133","volume":"9","author":"K Bohnenberger","year":"2019","unstructured":"Bohnenberger K, Liu MT (2019) Flubromazolam overdose: a review of a new designer benzodiazepine and the role of flumazenil. Ment Health Clin 9:133\u2013137. https:\/\/doi.org\/10.9740\/mhc.2019.05.133 (open access article)","journal-title":"Ment Health Clin"},{"key":"591_CR25","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s11419-019-00501-1","volume":"38","author":"Z Qian","year":"2020","unstructured":"Qian Z, Liu C, Huang J, Deng Q, Hua Z (2020) Identification of the designer benzodiazepine 8-chloro-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine (flualprazolam) in an anesthesia robbery case. Forensic Toxicol 38:269\u2013276. https:\/\/doi.org\/10.1007\/s11419-019-00501-1 (open access article)","journal-title":"Forensic Toxicol"},{"key":"591_CR26","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/add.14014","volume":"113","author":"J Haukka","year":"2018","unstructured":"Haukka J, Kriikku P, Mariottini C, Partonen T, Ojanper\u00e4 I (2018) Non-medical use of psychoactive prescription drugs is associated with fatal poisoning. Addiction 113:464\u2013472. https:\/\/doi.org\/10.1111\/add.14014","journal-title":"Addiction"},{"key":"591_CR27","first-page":"1","volume":"67","author":"H Hedegaard","year":"2018","unstructured":"Hedegaard H, Bastian BA, Trinidad JP, Spencer M, Warner M (2018) Drugs most frequently involved in drug overdose deaths: United States, 2011\u20132016. Natl Vital Stat Rep 67:1\u201314 (PMID:30707673)","journal-title":"Natl Vital Stat Rep"},{"key":"591_CR28","volume-title":"Disposition of toxic drugs and chemicals in man","author":"RC Baselt","year":"2020","unstructured":"Baselt RC (2020) Disposition of toxic drugs and chemicals in man, 12th edn. Biomedical Publications, Seal Beach","edition":"12"},{"key":"591_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.drugalcdep.2014.01.023","volume":"138","author":"S Darke","year":"2014","unstructured":"Darke S, Torok M, Duflou J (2014) Circumstances and toxicology of sudden or unnatural deaths involving alprazolam. Drug Alcohol Depend 138:61\u201366. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.01.023","journal-title":"Drug Alcohol Depend"},{"key":"591_CR30","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.forsciint.2014.01.005","volume":"236","author":"AK J\u00f6nsson","year":"2014","unstructured":"J\u00f6nsson AK, S\u00f6derberg C, Espnes KA, Ahlner J, Eriksson A, Reis M, Druid H (2014) Sedative and hypnotic drugs\u2014fatal and non-fatal reference blood concentrations. Forensic Sci Int 236:138\u2013145. https:\/\/doi.org\/10.1016\/j.forsciint.2014.01.005","journal-title":"Forensic Sci Int"},{"key":"591_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13054-020-02915-5","volume":"24","author":"M Schulz","year":"2020","unstructured":"Schulz M, Schmoldt A, Andresen-Streichert H, Iwersen-Bergmann S (2020) Revisited: therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics. Crit Care 24:195. https:\/\/doi.org\/10.1186\/s13054-020-02915-5 (open access article)","journal-title":"Crit Care"},{"key":"591_CR32","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/01.paf.0000153994.95642.c1","volume":"26","author":"BC Wolf","year":"2005","unstructured":"Wolf BC, Lavezzi WA, Sullivan LM, Middleberg RA, Flannagan LM (2005) Alprazolam-related deaths in Palm Beach County. Am J Forensic Med Pathol 26:24\u201327. https:\/\/doi.org\/10.1097\/01.paf.0000153994.95642.c1","journal-title":"Am J Forensic Med Pathol"},{"key":"591_CR33","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1177\/0269881112471155","volume":"27","author":"AW Jones","year":"2013","unstructured":"Jones AW, Holmgren A (2013) Concentrations of alprazolam in blood from impaired drivers and forensic autopsies were not much different but showed a high prevalence of co-ingested illicit drugs. J Psychopharmacol 27:276\u2013281. https:\/\/doi.org\/10.1177\/0269881112471155","journal-title":"J Psychopharmacol"},{"key":"591_CR34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1365-2125.2004.02089.x","volume":"58","author":"GK Isbister","year":"2004","unstructured":"Isbister GK, O\u2019Regan L, Sibbritt D, Whyte IM (2004) Alprazolam is relatively more toxic than other benzodiazepines in overdose. Br J Clin Pharmacol 58:88\u201395. https:\/\/doi.org\/10.1111\/j.1365-2125.2004.02089.x(open access article)","journal-title":"Br J Clin Pharmacol"},{"key":"591_CR35","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/jat\/21.3.218","volume":"21","author":"AJ Jenkins","year":"1997","unstructured":"Jenkins AJ, Levine B, Locke JL, Smialek JE (1997) A fatality due to alprazolam intoxication. J Anal Toxicol 21:218\u2013220. https:\/\/doi.org\/10.1093\/jat\/21.3.218 (open access article)","journal-title":"J Anal Toxicol"},{"key":"591_CR36","first-page":"432","volume":"36","author":"A Kakkar","year":"2014","unstructured":"Kakkar A, Kumar S (2014) Alprazolam poisoning. J Indian Acad Forensic Med 36:432\u2013433","journal-title":"J Indian Acad Forensic Med"},{"key":"591_CR37","unstructured":"Grohol J (2019) Top 25 psychiatric medication prescriptions for 2018. https:\/\/psychcentral.com\/blog\/top-25-psychiatric-medications-for-2018\/?li_source=LI&li_medium=popular17. Accessed 7 Jul 2021"},{"key":"591_CR38","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/ADM.0000000000000350","volume":"12","author":"N Ait-Daoud","year":"2018","unstructured":"Ait-Daoud N, Hamby AS, Sharma S, Blevins D (2018) A review of alprazolam use, misuse, and withdrawal. J Addict Med 12:4\u201310. https:\/\/doi.org\/10.1097\/ADM.0000000000000350 (free PMC article)","journal-title":"J Addict Med"},{"key":"591_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00004714-199008000-00002","volume":"10","author":"RR Griffiths","year":"1990","unstructured":"Griffiths RR, Wolf B (1990) Relative abuse liability of different benzodiazepines in drug abusers. J Clin Psychopharmacol 10:237\u2013243 (PMID:1981067)","journal-title":"J Clin Psychopharmacol"},{"key":"591_CR40","unstructured":"EMCDDA (2015) Perspectives in drugs \u2013 the misuse of benzodiazepines among high-risk opioid users in Europe. http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/2733\/Misuse%20of%20benzos_POD2015.pdf. Accessed 7 Jul 2021"},{"key":"591_CR41","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/00000433-199503000-00015","volume":"16","author":"K Uemura","year":"1995","unstructured":"Uemura K, Komura S (1995) Death caused by triazolam and ethanol intoxication. Am J Forensic Med Pathol 16:66\u201368. https:\/\/doi.org\/10.1097\/00000433-199503000-00015","journal-title":"Am J Forensic Med Pathol"},{"key":"591_CR42","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/s0379-0738(97)02110-5","volume":"86","author":"K Kudo","year":"1997","unstructured":"Kudo K, Imamura T, Jitsufuchi N, Zhang XX, Tokunaga H, Nagata T (1997) Death attributed to the toxic interaction of triazolam, amitriptyline and other psychotropic drugs. Forensic Sci Int 86:35\u201341. https:\/\/doi.org\/10.1016\/s0379-0738(97)02110-5","journal-title":"Forensic Sci Int"},{"issue":"Suppl 1","key":"591_CR43","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.1016\/s1344-6223(02)00074-3","volume":"5","author":"F Moriya","year":"2003","unstructured":"Moriya F, Hashimoto Y (2003) A case of fatal triazolam overdose. Leg Med 5(Suppl 1):S91\u2013S95. https:\/\/doi.org\/10.1016\/s1344-6223(02)00074-3","journal-title":"Leg Med"},{"key":"591_CR44","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4323\/rjlm.2012.297","volume":"20","author":"H Kinoshita","year":"2012","unstructured":"Kinoshita H, Tanaka N, Kuse A, Ohtsuki A, Nagasaki Y, Ueno Y, Jamal M, Tsutsui K, Kumihashi M, Ameno K (2012) An autopsy case of triazolam overdose. Rom J Leg Med 20:297\u2013298. https:\/\/doi.org\/10.4323\/rjlm.2012.297 (open access article)","journal-title":"Rom J Leg Med"},{"key":"591_CR45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/jat\/17.3.171","volume":"17","author":"BP Joynt","year":"1993","unstructured":"Joynt BP (1993) Triazolam blood concentrations in forensic cases in Canada. J Anal Toxicol 17:171\u2013177. https:\/\/doi.org\/10.1093\/jat\/17.3.171","journal-title":"J Anal Toxicol"},{"key":"591_CR46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3109\/15563650.2015.1112907","volume":"54","author":"M \u0141ukasik-G\u0142\u0119bocka","year":"2016","unstructured":"\u0141ukasik-G\u0142\u0119bocka M, Sommerfeld K, Te\u017cyk A, Zieli\u0144ska-Psuja B, Panie\u0144ski P, \u017baba C (2016) Flubromazolam\u2013a new life-threatening designer benzodiazepine. Clin Toxicol 54:66\u201368. https:\/\/doi.org\/10.3109\/15563650.2015.1112907","journal-title":"Clin Toxicol"},{"key":"591_CR47","unstructured":"TripSit FactSheets (2021) Flualprazolam. https:\/\/drugs.tripsit.me\/flualprazolam. Accessed 7 Jul 2021"},{"key":"591_CR48","unstructured":"Reddit (2021) Flualprazolam review. https:\/\/www.reddit.com\/r\/researchchemicals\/comments\/7m1qns\/flualprazolam_review\/. Accessed 7 Jul 2021"},{"key":"591_CR49","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.neuro.2019.02.015","volume":"73","author":"JB Zawilska","year":"2019","unstructured":"Zawilska JB, Wojcieszak J (2019) An expanding world of new psychoactive substances\u2014designer benzodiazepines. Neurotoxicology 73:8\u201316. https:\/\/doi.org\/10.1016\/j.neuro.2019.02.015","journal-title":"Neurotoxicology"},{"key":"591_CR50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/s0379-0738(00)00148-1","volume":"110","author":"R Dettmeyer","year":"2000","unstructured":"Dettmeyer R, Schmidt P, Musshoff F, Dreisvogt C, Madea B (2000) Pulmonary edema in fatal heroin overdose: immunohistological investigations with IgE, collagen IV and laminin\u2013no increase of defects of alveolar-capillary membranes. Forensic Sci Int 110:87\u201396. https:\/\/doi.org\/10.1016\/s0379-0738(00)00148-1","journal-title":"Forensic Sci Int"},{"key":"591_CR51","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/bcpt.12328","volume":"116","author":"C Eichbaum","year":"2015","unstructured":"Eichbaum C, Mathes K, Burhenne J, Markert C, Blank A, Mikus G (2015) Pre-systemic elimination of tilidine: localization and consequences for the formation of the active metabolite nortilidine. Basic Clin Pharmacol Toxicol 116:129\u2013133. https:\/\/doi.org\/10.1111\/bcpt.12328(open access article)","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"591_CR52","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1080\/08897077.2012.735216","volume":"34","author":"L Radbruch","year":"2013","unstructured":"Radbruch L, Glaeske G, Grond S, M\u00fcnchberg F, Scherbaum N, Storz E, Tholen K, Zagermann-Muncke P, Zieglg\u00e4nsberger W, Hoffmann-Menzel H, Greve H, Cremer-Schaeffer P (2013) Topical review on the abuse and misuse potential of tramadol and tilidine in Germany. Subst Abus 34:313\u2013320. https:\/\/doi.org\/10.1080\/08897077.2012.735216","journal-title":"Subst Abus"},{"key":"591_CR53","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/BF00351971","volume":"36","author":"M Van Boven","year":"1976","unstructured":"Van Boven M, Daenens P, Bruneel N (1976) A death case involving tilidine. Arch Toxicol 36:121\u2013125. https:\/\/doi.org\/10.1007\/BF00351971(open access article)","journal-title":"Arch Toxicol"},{"key":"591_CR54","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/jat\/11.3.105","volume":"11","author":"J Cordonnier","year":"1987","unstructured":"Cordonnier J, Van den Heede M, Heyndrickx A, Wennig R (1987) Disposition of tilidine in a fatal poisoning in man. J Anal Toxicol 11:105\u2013109. https:\/\/doi.org\/10.1093\/jat\/11.3.105","journal-title":"J Anal Toxicol"},{"key":"591_CR55","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/bcp.12731","volume":"81","author":"MLA Sivilotti","year":"2016","unstructured":"Sivilotti MLA (2016) Flumazenil, naloxone and the \u201ccoma cocktail.\u201d Br J Clin Pharmacol 81:428\u2013436. https:\/\/doi.org\/10.1111\/bcp.12731","journal-title":"Br J Clin Pharmacol"},{"key":"591_CR56","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1520\/JFS13208J","volume":"37","author":"AW Jones","year":"1992","unstructured":"Jones AW (1992) Ethanol distribution ratios between urine and capillary blood in controlled experiments and in apprehended drinking drivers. J Forensic Sci 37:21\u201334 (PMID:1545202)","journal-title":"J Forensic Sci"},{"key":"591_CR57","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/002580249003000203","volume":"30","author":"MK Heatley","year":"1990","unstructured":"Heatley MK, Crane J (1990) The blood alcohol concentration at post-mortem in 175 fatal cases of alcohol intoxication. Med Sci Law 30:101\u2013105. https:\/\/doi.org\/10.1177\/002580249003000203","journal-title":"Med Sci Law"},{"key":"591_CR58","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/s0379-0738(00)00163-8","volume":"110","author":"I Nordrum","year":"2000","unstructured":"Nordrum I, Eide TJ, J\u00f8rgensen L (2000) Alcohol in a series of medico-legally autopsied deaths in northern Norway 1973\u20131992. Forensic Sci Int 110:127\u2013137. https:\/\/doi.org\/10.1016\/s0379-0738(00)00163-8","journal-title":"Forensic Sci Int"},{"key":"591_CR59","volume-title":"Drug affecting the central nervous system","author":"LH Sternbach","year":"1968","unstructured":"Sternbach LH, Randall LO, Banziger R, Lehr H (1968) Structure-activity relationship in the 1,4-benzodiazepine series. In: Burger A (ed) Drug affecting the central nervous system. Edward Arnold, London"},{"key":"591_CR60","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1093\/clinchem\/26.11.1624","volume":"26","author":"KP Maguire","year":"1980","unstructured":"Maguire KP, Burrows GD, Norman TR, Scoggins BA (1980) Blood\/plasma distribution ratios of psychotropic drugs. Clin Chem 26:1624\u20131625 (PMID:6774839; open access article)","journal-title":"Clin Chem"}],"container-title":["Forensic Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11419-021-00591-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11419-021-00591-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11419-021-00591-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T18:26:29Z","timestamp":1641579989000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11419-021-00591-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["591"],"URL":"https:\/\/doi.org\/10.1007\/s11419-021-00591-w","relation":{},"ISSN":["1860-8965","1860-8973"],"issn-type":[{"value":"1860-8965","type":"print"},{"value":"1860-8973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,11]]},"assertion":[{"value":"3 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were in accordance with the national ethical standards (retrospective study) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}